←
Giandomenico Bisaccia, MD, PhD276 posts
Giandomenico Bisaccia, MD, PhD avatar

Giandomenico Bisaccia, MD, PhD

@bisacciaMD

MSc student @LSEHealthPolicy | MD-PhD @UnivUda | #WhyCMR fellow @RBandH

◷ Joined May 2019▧ 64 Photos and videos
Giandomenico Bisaccia, MD, PhD avatar
Giandomenico Bisaccia, MD, PhD@bisacciaMD·4 Aug 2024

Heart transplant recipients deserve the diagnostic precision of quantitative #stressCMR Read our latest research on EHJ Cardiovascular Imaging academic.oup.com/ehjcimaging… @chiarabd @fabrizioricci @giulialavecchi3

Safety and feasibility of adenosine stress cardiac MRI in heart transplant recipients academic.oup.com/ehjcimaging… #EHJCVI @chiarabd #WhyCMR @GeraldMaurer @alessia_gimelli @Sarah_Moharem @vass_vassiliou @AnnaKateBarton

Post attachment
Giandomenico Bisaccia, MD, PhD avatar
Giandomenico Bisaccia, MD, PhD@bisacciaMD·4 Aug 2024

Super proud of having done PhD work @RBandH with you @chiarabd! And special thanks to my fellow colleagues incl @giulialavecchi3 More to come from our Harefield team 😉

Thank you @HanCardiomd for showcasing our research! 🙏 Great work from @bisacciaMD and all my team at #HarefieldHospital @RBandH #whyCMR ❤️ adenosine: safe stressor post heart transplant ❤️quantitive stress CMR ⬆️ value vs visual to predict CAV (cardiac allograft vasculopathy)

Frank Harrell avatar
⟳ Giandomenico Bisaccia, MD, PhD retweeted
Frank Harrell@f2harrell·4 Apr 2024

And how can we applaud a study that published an analysis that is not consistent with the parallel-group design and didn't recognize serious problems with change from baseline?

C Bucciarelli-Ducci avatar
⟳ Giandomenico Bisaccia, MD, PhD retweeted
C Bucciarelli-Ducci@chiarabd·25 Mar 2024

Congrats to @bisacciaMD for very capably defending his PhD thesis and work done at @RBandH. Thank you to external examiner @rmanka_ ! Very proud of you Giando, you are a very bright 🌟 and talented young colleague! I am looking forward to the many successes awaiting you!🤩

Post attachmentPost attachmentPost attachment
NonsparseOncologist avatar
⟳ Giandomenico Bisaccia, MD, PhD retweeted
NonsparseOncologist@5_utr·1 Feb 2024

The money spent on astronomical priced drugs in the metastatic setting based on false assumptions, including ignoring tumor heterogeneity and evolution, would be much better spent on prevention, early detection, local treatment

Ritu Thamman MD avatar
⟳ Giandomenico Bisaccia, MD, PhD retweeted
Ritu Thamman MD@iamritu·26 Jan 2024

M Salerno #CMR2024 ⭐️ NICM abnl perfusion w global⬇️ in MBF & MPR, worse in subendocardium May need a higher dose of adenosine in NICM with EF <35% MVD in HCM diffuse, worse w thicker myocardium + fibrosis subendocardial ischemia pattern depends on phenotype: septal in ASH 🆚 apical in ApHCM HFpEF MVD common & Abnl Perfusion reserve assoc w worse clinical outcomes

Post attachmentPost attachmentPost attachmentPost attachment
ASA History of Statistics Special Interest Group avatar
⟳ Giandomenico Bisaccia, MD, PhD retweeted
ASA History of Statistics Special Interest Group@HOS_ASA·26 Jan 2024

In Jan 1977 a distinguished group of British 🇬🇧& American 🇺🇸statisticians led by Sir Richard Peto published the first methodological tutorial on survival data analysis specifically intended for non-statisticians. 1/3

Post attachmentPost attachmentPost attachmentPost attachment
Giandomenico Bisaccia, MD, PhD avatar
Giandomenico Bisaccia, MD, PhD@bisacciaMD·17 Jan 2024

Excited to be joining an international pool of experts and friends from all over the world next week at #CMR2024. Privileged to present four original abstracts including an Early Career Award on 26th Jan. See you there! @chiarabd @rmanka_ @EACVIPresident @purviparwani #whyCMR

London calling 🇬🇧 #CMR2024! Everything is ready to welcome you in 2 weeks, largest ever @whyCMR conference in CV medicine. Final agenda scmr.org/page/CMR2024-agenda. Registration in person or online scmr.org/page/CMR2024--regis… @ThomasTreibel @JStojanovskaMD @RNijveldt @karen_ordovas

Post attachmentPost attachmentPost attachment